Pesquisas alternativas:
oil » soil (Expandir a Pesquisa)
care » case (Expandir a Pesquisa), carle (Expandir a Pesquisa)
car » carl (Expandir a Pesquisa)
oil » soil (Expandir a Pesquisa)
care » case (Expandir a Pesquisa), carle (Expandir a Pesquisa)
car » carl (Expandir a Pesquisa)
1
“...Angiopoietin-1 is a promoter of physiological vasculogenesis and angiogenesis because it induces...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Marsland, Anna L., Long, Kristin A., Howe, Chelsea, Thompson, Amanda L., Tersak, Jean, Ewing, Linda J.
Publicado em 2013
“...Objectives (1) To examine the acceptability and feasibility of a stress management intervention...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Capellades, J., Puig, J., Domenech, S., Diaz, R., Oleaga, L., Pujol, T., Camins, A., Majos, C., de Quintana, C., Balana, C.
Publicado no Neuro Oncol (2017)
“... (stages I, II, and III) integrating tumor location (A, B, C), size (≤5 cm or >5cm), and eloquence...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
4
Por Carlsson, A, Kockum, I, Lindblad, B, Engleson, L, Nilsson, A, Forsander, G, Karlsson, A-K, Kernell, A, Ludvigsson, J, Marcus, C, Zachrisson, I, Ivarsson, S-A, Lernmark, Å
Publicado em 2011
“... diabetes children with the A1*05:01-B1*02:01 haplotype was most pronounced in children diagnosed between 5...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Sessions, October M., Barrows, Nicholas J., Souza-Neto, Jayme A., Robinson, Timothy J., Hershey, Christine L., Rodgers, Mary A., Ramirez, Jose L., Dimopoulos, George, Yang, Priscilla L., Pearson, James L., Garcia-Blanco, Mariano A.
Publicado em 2009
“...-glucosidases)(3-5, 7, 9, 10), most DVHFs were newly implicated in DENV propagation. The dipteran DVHFs had...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... to monitor treatment effects and assess patients' needs. Inspection time, a measure of the efficiency...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Bacha, J. A., Steino, A., Schwartz, R., Langlands, J., Kanekal, S., Lopez, L. M., Brown, D. M.
Publicado no Neuro Oncol (2017)
“... in bevacizumab-naïve patients (clinicaltrials.gov identifier: NCT02717962). iii) A single arm Phase 2 study...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
8
Por Vardy, J, Jenkins, P J, Clark, K, Chekroud, M, Begbie, K, Anthony, I, Rymaszewski, L A, Ireland, A J
Publicado em 2014
“... in standardised treatment pathways, leaflet supported discharge and a virtual fracture clinic review. Patients...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Sasseville, V. G., Mansfield, K. G., Mankowski, J. L., Tremblay, C., Terio, K. A., Mätz-Rensing, K., Gruber-Dujardin, E., Delaney, M. A., Schmidt, L. D., Liu, D., Markovits, J. E., Owston, M., Harbison, C., Shanmukhappa, S., Miller, A. D., Kaliyaperumal, S., Assaf, B. T., Kattenhorn, L., Macri, S. Cummings, Simmons, H. A., Baldessari, A., Sharma, P., Courtney, C., Bradley, A., Cline, J. M., Reindel, J. F., Hutto, D. L., Montali, R. J., Lowenstine, L. J.
Publicado em 2012
“... nonhuman primates for biomedical research has significantly affected populations. There remains a need...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Dieterich, Daniela C., Hodas, Jennifer J.L., Gouzer, Geraldine, Shadrin, Ilya Y., Ngo, John T., Triller, Antoine, Tirrell, David A., Schuman, Erin M.
Publicado em 2010
“... particle tracking and quantum dots. The newly synthesized proteins exhibited a broad range of diffusive...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Abramson, J. S., Feldman, T., Kroll-Desrosiers, A. R., Muffly, L. S., Winer, E., Flowers, C. R., Lansigan, F., Nabhan, C., Nastoupil, L. J., Nath, R., Goy, A., Castillo, J. J., Jagadeesh, D., Woda, B., Rosen, S. T., Smith, S. M., Evens, A. M.
Publicado no Ann Oncol (2014)
“...), and 74% had stage III-IV disease. Twenty-three (7%) patients received only palliative care whereas 318...”Publicado no Ann Oncol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Dhall, G., Ji, L., Haley, K., Gilles, F., Gardner, S., Sposto, R., Finlay, J. L.
Publicado no Neuro Oncol (2017)
“... trials. We report the outcome of young children with NDMB treated on “Head Start” III, a prospective...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
13
Por Dhall, G., Ji, L., Haley, K., Gilles, F., Gardner, S., Sposto, R., Finlay, J. L.
Publicado no Neuro Oncol (2017)
“...)” III, a prospective, multi-national clinical trial. Methods: Between April 2003 and December 2009, 92...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
14
Por N. L. Petrova, A. Whittam, A. MacDonald, S. Ainarkar, A. N. Donaldson, J. Bevans, J. Allen, P. Plassmann, B. Kluwe, F. Ring, L. Rogers, R. Simpson, G. Machin, M. E. Edmonds
Publicado em 2018-05-01
“... the right and left foot at five regions of interest (ROIs), including 1st and 4th toes, 1st, 3rd and 5th...”Publicado em 2018-05-01
Obter o texto integral
Artigo
15
Por J.M. Mercadé Cerdá, J.A. Mauri Llerda, J.L. Becerra Cuñat, J. Parra Gomez, A. Molins Albanell, C. Viteri Torres, F.J. López Gonzalez, X. Salas Puig
Publicado em 2015-07-01
“... (FAE), o no conseguirla a pesar de un tratamiento oportuno.El tratamiento con FAE es recomendable...”Publicado em 2015-07-01
Obter o texto integral
Artigo
16
“... the initial phase of cancer care is largely unknown. Methods We used a claims database to identify adults...”
Obter o texto integral
Obter o texto integral
Artigo
17
Por Wirsching, H. G., Tabatabai, G., Hottinger, A., Plasswilm, L., Roelcke, U., Conen, K., Held, L., Rushing, E. J., Ochsenbein, A., Weller, M.
Publicado no Neuro Oncol (2017)
“...BACKGROUND: Two phase III trials of bevacizumab (BEV) in newly diagnosed glioblastoma demonstrated...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
18
Por Cohen, Kenneth J., Heideman, Richard L., Zhou, Tianni, Holmes, Emiko J., Lavey, Robert S., Bouffet, Eric, Pollack, Ian F.
Publicado em 2011
“...)/day for 5 days every 28 days, for a total of 10 cycles. The primary objective of the statistical...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por T. M. Ripping, L. A. Kiemeney, L. M. C. van Hoogstraten, J. A. Witjes, K. K. H. Aben, on behalf of the BlaZIB study group
Publicado em 2020-05-01
Assuntos:
“...Quality of care...”Publicado em 2020-05-01
Obter o texto integral
Artigo
20
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing...
Por Traboulsee, A, Li, DKB, Tam, R, Zhao, G, Riddehough, A, Fang, J, Dangond, F, Kappos, L
Publicado no Mult Scler J Exp Transl Clin (2017)
“... of newly evolved CBH was numerically reduced. A numerically higher proportion of patients with ≥1 evolving...”Publicado no Mult Scler J Exp Transl Clin (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo